Gubertini G, Scorza D, Beccari M, Buccianti G, Costantino A, Spotti D, Graziani G
Second Department of Infectious Diseases, L. Sacco Hospital, Milan, Italy.
Nephron. 1992;61(3):271-2. doi: 10.1159/000186902.
We studied the seroprevalence of antibodies to hepatitis C virus (HCV Ab) in a cohort of 229 chronic hemodialysis patients followed by 6 Dialysis Units in the Milan area. HCV Ab was present in 51 (22.3%) of 229 examined patients. Previous blood transfusions and surgery did not clearly influence HCV seroconversion, whereas duration of dialysis treatment seems to be strictly related to HCV Ab positivity.
我们对米兰地区6个透析单元所跟踪的229例慢性血液透析患者队列进行了丙型肝炎病毒抗体(HCV Ab)血清流行率研究。在229例接受检测的患者中,51例(22.3%)存在HCV Ab。既往输血和手术对HCV血清转化无明显影响,而透析治疗时间似乎与HCV Ab阳性密切相关。